Surgical treatment of lymph node metastases in stage IB cervical cancer. the laterally extended parametrectomy (LEP) procedure: Experience with a 5 year follow-up

Gynecologic Oncology

Volumn 123, Issue 2, 2011, Pages 337-341

  Ungár, László ^a   Pálfalvi, László ^a   Tarnai, László ^b   Horányi, Dániel ^a   Novák, Zoltán ^b  

^a Saint Stephen Hospital   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Cervical cancer; Laterally extended parametrectomy; Lymph node metastasis

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BLADDER DISEASE; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; DISEASE SEVERITY; FEMALE; FEVER; FOLLOW UP; GYNECOLOGIC SURGERY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILEUS; INCONTINENCE; LATERALLY EXTENDED PARAMETRECTOMY; LEG EDEMA; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; NECROSIS; OVERALL SURVIVAL; PELVIC LYMPH NODE METASTASIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; QUALITY OF LIFE; REOPERATION; SURGICAL PATIENT; THROMBOSIS; TREATMENT INDICATION; TREATMENT OUTCOME; URETER INJURY; URETER STRICTURE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; UTERINE CERVICAL NEOPLASMS;

EID: 80054716831     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.07.001     Document Type: Article

References (38)

1. P.F. van Bommel, A.C. van Lindert, H.C. Kock, W.H. Leers, and J.P. Neijt A review of prognostic factors in early-stage carcinoma of the cervix (FIGO I B and II A) and implications for treatment strategy Eur J Obstet Gynecol Reprod Biol 26 1 1987 69 84
2. J. Kodama, N. Seki, S. Masahiro, T. Kusumoto, K. Nakamura, A. Hongo, and Y. Hiramatsu Prognostic factors in stage IB-IIB cervical adenocarcinoma patients treated with radical hysterectomy and pelvic lymphadenectomy J Surg Oncol 101 5 2010 413 417
3. R.A. Ware, and J.R. van Nagell Radical hysterectomy with pelvic lymphadenectomy: indications, technique, and complications Obstet Gynecol Int 2010 [2010. pii: 587610]
4. A.F. Fuller Jr. , N. Elliott, C. Kosloff, and J.L. Lewis Jr. Lymph node metastases from carcinoma of the cervix, stages IB and IIA: implications for prognosis and treatment Gynecol Oncol 13 2 1982 165 174
5. T. Inoue, and K. Morita The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB Cancer 65 9 1990 1923 1927
6. O.K. Macdonald, J. Chen, M. Dodson, and C.M. Lee Gaffney DK Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix Am J Clin Oncol 32 4 2009 411 416
7. R.D. Alvarez, S.J. Soong, W.K. Kinney, G.C. Reid, M.F. Schray, K.C. Podratz, G.W. Morley, and H.M. Shingleton Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix Gynecol Oncol 35 2 1989 130 135
8. P.W. Martimbeau, K.E. Kjorstad, and T. Iversen Stage IB carcinoma of the cervix, the Norwegian Radium hospital. II. Results when pelvic nodes are involved Obstet Gynecol 60 2 1982 215 218
9. G. Delgado, B. Bundy, R. Zaino, B.U. Sevin, W.T. Creasman, and F. Major Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study Gynecol Oncol 38 3 1990 352 357
10. C.P. Morrow Panel report. Is pelvic radiation beneficial in the postoperative management of stage IB squamous cell carcinoma of the cervix with pelvic node metastasis treated by radical hysterectomy? Gynecol Oncol 10 1980 105 110
11. W.K. Kinney, R.D. Alvarez, G.C. Reid, M.F. Schray, S.J. Soong, G.W. Morley, K.C. Podratz, and H.M. Shingleton Value of adjuvant whole-pelvis irradiation after Wertheim hysterectomy for early-stage squamous carcinoma of the cervix with pelvic nodal metastasis: a matched-control study Gynecol Oncol 34 3 1989 258 262
12. M. Höckel Pelvic recurrences of cervical cancer J Pelvic Surg 5 1999 255 266
13. A. Covens, B. Rosen, J. Murphy, S. Laframboise, A.D. DePetrillo, G. Lickrish, T. Colgan, W. Chapman, and P. Shaw How important is removal of the parametrium at surgery for carcinoma of the cervix? Gynecol Oncol 84 1 2002 145 149
14. P. Benedetti-Panici, F. Maneschi, G. D'Andrea, G. Cutillo, C. Rabitti, M. Congiu, F. Coronetta, and A. Capelli Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study Cancer 88 10 2000 2267 2274
15. E. Burghardt, H. Pickel, J. Haas, and M. Lahousen Prognostic factors and operative treatment of stages IB to IIB cervical cancer Am J Obstet Gynecol 156 4 1987 988 996
16. F. Girardi, W. Lichtenegger, K. Tamussino, and J. Haas The importance of parametrial lymph nodes in the treatment of cervical cancer Gynecol Oncol 34 2 1989 206 211
17. L. Ungar, and L. Palfalvi Surgical treatment of lymph node metastases in stage IB cervical cancer: the laterally extended parametrectomy (LEP) procedure Int J Gynecol Cancer 13 5 2003 647 651
18. L. Palfalvi, and L. Ungar Laterally extended parametrectomy (LEP), the technique for radical pelvic side wall dissection: feasibility, technique and results Int J Gynecol Cancer 13 6 2003 914 917
19. K.Y. Terada, G.W. Morley, and J.A. Roberts Stage IB carcinoma of the cervix with lymph node metastases Gynecol Oncol 31 3 1988 389 395
20. T. Uno, H. Ito, J. Itami, T. Sato, S. Minoura, S. Yasuda, T. Aruga, K. Isobe, N. Shigematsu, and A. Kubo Adjuvant pelvic irradiation in patients with pathologic T2b carcinoma of the uterine cervix Int J Gynecol Cancer 12 2 2002 187 191
21. W.A. Peters, P.Y. Liu, R.J. Barrett, R.J. Stock, B.J. Monk, J.S. Berek, L. Souhami, P. Grigsby, W. Gordon, and D.S. Alberts Concurrant chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 8 2000 1606 1613
22. S. Mabuchi, M. Okazawa, F. Isohashi, Y. Ohta, S. Maruoka, Y. Yoshioka, T. Enomoto, K. Morishige, S. Kamiura, and T. Kimura Postoperative whole pelvic radiotherapy plus concurrent chemotherapy versus extended-field irradiation for early-stage cervical cancer patients with multiple pelvic lymph node metastases Gynecol Oncol 120 1 2011 94 100
23. B. Mossa, S. Mossa, and R. Marziani Adjuvant chemotherapy versus radiation therapy after radical surgery in high-risk positive node stage IB/IIA cervical cancer Eur J Gynaecol Oncol 31 5 2010 545 550
24. G. Garg, J.P. Shah, E.P. Toy, J.B. Field, C.S. Bryant, J.R. Liu, and R.T. Morris Intra-operative detection of nodal metastasis in early stage cervical cancer: a survey of the practice patterns of SGO members Gynecol Oncol 121 1 2011 143 147
25. A.C.O.G. Practice Bulletin, clinical management guidelines for obstetrician-gynecologists. No. 35, May 2002: diagnosis and treatment of cervical carcinomas Obstet Gynecol 99 5 2002 855 866
26. M. Höckel, L.C. Horn, N. Manthey, U.D. Braumann, U. Wolf, G. Teichmann, K. Frauenschläger, N. Dornhöfer, and J. Einenkel Resection of the embryologically defined uterovaginal (Müllerian) compartment and pelvic control in patients with cervical cancer: a prospective analysis Lancet Oncol 10 7 2009 683 692
27. J.Y. Park, D.Y. Kim, J.H. Kim, Y.M. Kim, Y.T. Kim, and J.H. Nam Further stratification of risk groups in patients with lymph node metastasis after radical hysterectomy for early-stage cervical cancer Gynecol Oncol 117 1 2010 53 58
28. H.E. Averette, M.W. Method, B.-U. Sevin, and M.A. Penalver Radical abdominal hysterectomy in the primary management of invasive cervical cancer S.C. Rubin, W.J. Hoskins, Cervical cancer and preinvasive neoplasia 1996 Lippincott-Raven Publishers Philadelphia 189 206
29. E.A. Frankman, L. Wang, C.H. Bunker, and J.L. Lowder Lower urinary tract injury in women in the United States, 1979-2006 Am J Obstet Gynecol 202 5 2010 495 505
30. G. Ralph, R. Winter, L. Michelitsch, and K. Tamussino Radicality of parametrial resection and dysfunction of the lower urinary tract after radical hysterectomy Eur J Gynaecol Oncol 12 1 1991 27 30
31. R. Naik, K.S. Jackson, A. Lopes, P. Cross, and J.A. Henry Laparoscopic assisted radical vaginal hysterectomy versus radical abdominal hysterectomy-a randomised phase II trial: perioperative outcomes and surgicopathological measurements BJOG 117 6 2010 746 751
32. F. Pettersson, S. Fotiou, N. Einhorn, and C. Silfverswärd Cohort study of the long-term effect of irradiation for carcinoma of the uterine cervix. Second primary malignancies in the pelvic organs in women irradiated for cervical carcinoma at Radiumhemmet 1914-1965 Acta Radiol Oncol 24 2 1985 145 151
33. F. Pettersson, M. Ryberg, and B. Malker Second primary cancer after treatment of invasive carcinoma of the uterine cervix, compared with those arising after treatment for in situ carcinomas. An effect of irradiation? A cancer registry study Acta Obstet Gynecol Scand 69 2 1990 161 174
34. F. Landoni, A. Maneo, A. Colombo, F. Placa, R. Milani, and P. Perego Randomised study of radical surgery versus radiotherapy for stage I/b-II/a cervical cancer Lancet 350 1997 535 540
35. K. Kashima, T. Yahata, K. Fujita, and K. Tanaka Analysis of the complications after radical hysterectomy for stage IB, IIA and IIB uterine cervical cancer patients J Obstet Gynaecol Res 36 3 2010 555 559
36. M.H. Hazewinkel, M.A. Sprangers, J. van der Velden, C.H. van der Vaart, L.J. Stalpers, M.P. Burger, and J.P. Roovers Long-term cervical cancer survivors suffer from pelvic floor symptoms: a cross-sectional matched cohort study Gynecol Oncol 117 2 2010 281 286
37. U. Güth, W.A. Ella, A. Olaitan, R.J. Hadwin, R. Arora, and M. McCormack Total vaginal necrosis: a representative example of underreporting severe late toxic reaction after concomitant chemoradiation for cervical cancer Int J Gynecol Cancer 20 1 2010 54 60
38. M. Undurraga, P. Loubeyre, J.B. Dubuisson, D. Schneider, and P. Petignat Early-stage cervical cancer: is surgery better than radiotherapy? Expert Rev Anticancer Ther 10 3 2010 451 460